The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.
Kryshtopava M.A.
Vitebsk State Order of Friendship of Peoples Medical University
Alenskaya T.L.
Vitebsk State Order of Friendship of Peoples Medical University
Azaronak M.K.
Vitebsk State Order of Friendship of Peoples Medical University
Voice disorders associated with novel coronavirus infection
Journal: Russian Bulletin of Otorhinolaryngology. 2023;88(6): 30‑37
Views: 1025
Downloaded: 4
To cite this article:
Kryshtopava MA, Alenskaya TL, Azaronak MK, Petrova LG. Voice disorders associated with novel coronavirus infection. Russian Bulletin of Otorhinolaryngology.
2023;88(6):30‑37. (In Russ.)
https://doi.org/10.17116/otorino20238806130
To evaluate the features of voice disorders associated with novel coronavirus infection and to develop the clinical algorithm for diagnostic and treatment these patients.
A prospective observational study was conducted in patients with dysphonia after COVID-19 (n=60). All patients underwent a comprehensive voice assessment before and after the proposed treatment. The follow-up period was 1 month.
Functional dysphonia or aphonia with a stable (refractory) or recurrent course was diagnosed in 58 (97%) patients. A tendency to an increase in the value of the latent period of the P300 and MMN in patients with voice disorder was revealed. There was a significant decrease in supraglottic constriction and glottal insufficiency before and after the treatment. The mean VHI-10 decreased from 25.4 before treatment to 15.3 after treatment. The DSI which is based on the set of voice measurements, statistically significant improved from –5.2 to 2.6 in patients as a result of treatment. The average value of MFI-20 improved from 65.4 (8.7) at the beginning of the study to 20.3 (5.3) after treatment.
In patients with dysphonia or aphonia associated with COVID-19 are indicated a refractory type of dysphonia. This was indicated by the study of AEPs of the brain. The clinical algorithm for treatment and diagnostic patients with voice disorders after COVID-19 has been developed. The treatment of this group of patients should be adjunct by the drug therapy, kinesiotaping method and psychotherapy.
Keywords:
Authors:
Kryshtopava M.A.
Vitebsk State Order of Friendship of Peoples Medical University
Alenskaya T.L.
Vitebsk State Order of Friendship of Peoples Medical University
Azaronak M.K.
Vitebsk State Order of Friendship of Peoples Medical University
Received:
23.09.2022
Accepted:
20.03.2023
List of references:
Close metadata
Email Confirmation
An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.
Email Confirmation
Log in to the site using your account in one of the services
We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.